Sabra Healthcare REIT, Inc. $SBRA is Leisure Capital Management’s 5th Largest Position

Leisure Capital Management boosted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 9.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 583,042 shares of the real estate investment trust’s stock after buying an additional 52,030 shares during the quarter. Sabra Healthcare REIT accounts for approximately 3.7% of Leisure Capital Management’s portfolio, making the stock its 5th biggest position. Leisure Capital Management’s holdings in Sabra Healthcare REIT were worth $11,043,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of SBRA. Focus Partners Wealth raised its position in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after buying an additional 2,375 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after buying an additional 1,536 shares during the last quarter. First Trust Advisors LP raised its position in Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after buying an additional 78,709 shares during the last quarter. Cerity Partners LLC raised its position in Sabra Healthcare REIT by 73.0% in the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after buying an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its position in Sabra Healthcare REIT by 3.1% in the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after buying an additional 2,557 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SBRA has been the subject of a number of analyst reports. Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. Citizens Jmp increased their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Cantor Fitzgerald increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. UBS Group increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, February 19th. Finally, Wall Street Zen lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.00.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock opened at $20.68 on Monday. Sabra Healthcare REIT, Inc. has a 1 year low of $17.04 and a 1 year high of $21.07. The firm has a market cap of $5.21 billion, a PE ratio of 32.31, a P/E/G ratio of 1.65 and a beta of 0.67. The stock has a fifty day moving average price of $20.17 and a 200-day moving average price of $19.21. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. During the same period in the prior year, the business earned $0.36 earnings per share. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 187.50%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.